Invuity Announces Pricing of Public Offering of Common Stock
July 28 2016 - 9:00AM
Invuity, Inc. (NASDAQ:IVTY) ("Invuity" or the "Company"), a leading
surgical photonics company, today announced the pricing of its
public offering of 2.8 million shares of its common stock at a
price to the public of $10.00 per share. In addition, the Company
has granted the underwriters a 30-day option to purchase up to
420,000 additional shares of its common stock.
Piper Jaffray & Co. and Leerink Partners LLC are acting as
joint book-running managers for the offering. William Blair &
Company, L.L.C. is acting as a co-manager for the offering.
The offering is being made pursuant to an effective shelf
registration statement on Form S-3 (No. 333-212395) that was
initially filed with the U.S. Securities and Exchange Commission
(the "SEC") on July 1, 2016. A preliminary prospectus supplement
describing the terms of the offering has been filed with the SEC
and forms a part of the effective registration statement. Copies of
the preliminary prospectus supplement and the accompanying
prospectus relating to the offering, and when available, copies of
the final prospectus supplement and the accompanying prospectus
relating to the offering may be obtained from the offices of Piper
Jaffray & Co., Attention: Prospectus Department, 800 Nicollet
Mall, J12S03, Minneapolis, MN 55402, or by e-mail at
prospectus@pjc.com or by telephone at (800) 747-3924 or
Leerink Partners LLC, Attention: Syndicate Department, One Federal
Street, 37th Floor, Boston, MA 02110, or by e-mail at
Syndicate@Leerink.com or by telephone at (800) 808-7525 ext.
6142.
This press release shall not constitute an offer to sell or the
solicitation of an offer to buy, nor shall there be any sale of
these securities in any state or jurisdiction in which such offer,
solicitation or sale would be unlawful prior to registration or
qualification under the securities laws of any such state or
jurisdiction.
About Invuity®
Invuity, Inc. is a medical technology company focused on
developing and marketing advanced photonics devices to improve the
ability of surgeons to illuminate and visualize the surgical cavity
during open minimally invasive and minimal access surgery. The
Company's patented Intelligent Photonics™ technology enables
enhanced surgical precision, efficiency and safety by providing
superior visualization. Clinical applications include breast and
thyroid oncology, plastic reconstructive, spine, orthopedic,
cardiothoracic and general surgery among others. Invuity is
headquartered in San Francisco, CA.
Forward-Looking Statements
This announcement contains forward-looking statements within the
meaning of the Securities Act of 1933, as amended, the Securities
Exchange Act of 1934, as amended, and the Private Securities
Litigation Reform Act of 1995. These forward-looking statements,
including statements regarding the public offering, are subject to
a number of risks and uncertainties which may cause actual results
or outcomes to be materially different from those expressed or
implied by the forward-looking statements. These risks and
uncertainties include market risks and uncertainties and risks and
uncertainties relating to the satisfaction of customary closing
conditions for an underwritten offering of securities, as well as
the risks and uncertainties that could affect the Company’s
business and financial results described in the preliminary
prospectus supplement and registration statement referenced above,
as well as the Company’s other filings with the SEC, including,
without limitation, under the caption "Risk Factors."
There can be no assurance that the Company will be able to
complete the public offering on the anticipated terms, or at all.
Forward-looking statements relate only to events as of the date on
which the statements are made, and the Company undertakes no
obligation to publicly update or review any forward-looking
statement.
CONTACT:
Company Contact:
Jim Mackaness
Chief Financial Officer
Invuity, Inc.
415-655-2129
Investors:
Mark Klausner
Westwicke Partners
443-213-0501
irdept@invuity.com
INVUITY, INC. (NASDAQ:IVTY)
Historical Stock Chart
From Jun 2024 to Jul 2024
INVUITY, INC. (NASDAQ:IVTY)
Historical Stock Chart
From Jul 2023 to Jul 2024